台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-群益金鼎-古亭 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

群益金鼎-古亭 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/07466.2000.0065.9044810.83%
2025/04/300.462.5000.0059.600.44700.07%
2025/04/210.262.00258.9558.00-1.8475-0.38%
2025/04/16259.4000.0059.0024900.41%
2025/04/15660.0000.0060.1064901.22%
2025/03/2100.00372.6772.40-3594-0.51%
2025/03/1800.00175.1075.50-1602-0.16%
2025/03/1200.001979.7677.50-19585-3.24%
2025/03/111778.5400.0081.50175573.05%
2025/03/10272.1000.0076.8025180.39%
2025/02/26166.2000.0066.4014900.20%
2025/02/24167.6000.0068.0015040.20%
2025/01/2200.000.360.4060.90-0.3604-0.05%
2024/12/2500.00175.1074.00-1683-0.15%
2024/12/241.370.3900.0073.001.36770.19%
2024/12/2000.00260.5060.40-2684-0.29%
2024/12/19263.6500.0062.7026950.29%
2024/12/1700.00354.9755.40-3678-0.44%
2024/12/11155.1000.0054.9016660.15%
2024/11/26168.7000.0068.6016810.15%
2024/11/25172.0000.0071.9016810.15%
2024/11/22173.70372.4073.00-2672-0.30%
2024/11/14065.9000.0069.0006700.00%
2024/11/13163.2000.0064.0016520.15%
2024/11/12263.1500.0070.0026320.32%
2024/11/11370.2300.0070.1036060.49%
2024/11/05184.9000.0084.9016360.16%
2024/10/1400.000.3122.50121.00-0.3817-0.03%
2024/10/070.3117.002117.00116.50-1.8830-0.21%
2024/09/300.1108.0000.00108.000.17770.01%
2024/09/270.1121.5000.00120.000.17960.01%
2024/09/260.2134.6700.00133.000.27850.02%
2024/09/250.1150.0000.00147.500.17840.01%
2024/09/242160.001168.50159.0017890.13%
2024/09/234158.3800.00158.0047940.50%
2024/09/183179.500177.00175.0037790.38%
2024/09/131182.5000.00178.0017790.13%
2024/08/282216.0000.00210.0027880.25%
2024/08/271220.5000.00220.0017850.13%
2024/08/2300.001229.00229.00-1798-0.13%
2024/08/211223.002219.00225.00-1802-0.12%
2024/08/203214.061218.00216.0028060.25%
2024/08/1600.003199.00200.50-3822-0.36%
2024/08/153192.001196.50191.5028270.24%
2024/08/141190.5000.00192.0018410.12%
2024/08/133191.6700.00189.0038430.36%
2024/08/091203.503186.00203.50-2824-0.24%
2024/08/083187.005186.10187.00-2794-0.25%
2024/08/071177.0000.00180.0017810.13%
2024/08/0600.001175.00171.00-1777-0.13%
2024/08/051180.004177.50180.00-3768-0.39%
2024/08/023178.002173.00177.5017490.13%
2024/08/0100.001170.00175.50-1732-0.14%
2024/07/313157.6700.00161.0037270.41%
2024/07/2900.004145.50141.50-4708-0.56%
2024/07/262151.251152.50148.0017000.14%
2024/07/232161.503155.67160.00-1685-0.15%
2024/07/191183.0000.00182.0016500.15%
2024/07/184195.252192.00196.5026110.33%
2024/07/172184.502190.00191.0005890.00%
2024/07/161173.0000.00174.5015660.18%
2024/07/1200.000.1163.00162.00-0.1544-0.02%
2024/07/111154.003153.83149.00-2531-0.38%
2024/07/101152.5000.00152.5015120.19%
2024/07/0900.005138.50139.00-5499-1.00%
2024/07/084137.632138.00138.5024930.41%
2024/07/0500.001127.00127.50-1480-0.21%
2024/07/0400.002126.25126.00-2477-0.42%
2024/07/033130.833127.00124.5004740.00%
2024/07/0200.003137.67138.00-3446-0.67%
2024/07/013131.333134.33137.5004350.00%
2024/06/283122.003130.00130.0004130.00%
2024/06/2700.000.7118.00118.50-0.7393-0.18%
2024/06/2600.002103.00108.00-2378-0.53%
2024/06/214105.7500.00106.0043681.09%
2024/06/203105.5000.00105.0033720.81%
2024/06/195101.4000.00101.5053741.34%
2024/06/183106.5000.00104.5033640.82%
2024/06/12196.5000.0097.4013270.31%
2024/06/1100.003102.00101.50-3324-0.92%
2024/06/03193.7000.0093.0013150.32%
2024/05/2900.00199.0094.50-1319-0.31%
2024/05/2400.00399.47105.00-3298-1.00%
2024/05/2200.000.193.0091.50-0.1260-0.05%
2024/05/2000.000.785.0086.30-0.7238-0.29%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音